Concepedia

Jason Duquette

JD

Statistics

Publications

16

Citations

1.1K

H-Index

16

Active since

2003

Affiliations

Amgen (United States)(Current)

Bayer (United States)

Jason Duquette is an author at Amgen (United States) specializing in drug discovery, medicine, and pharmacology.

Top concepts

Publications per year

2003–2016

16

Publications

16

Discovery of AMG 232, a Potent, Selective, and Orally Bioavailable MDM2–p53 Inhibitor in Clinical Development

Daqing Sun, Zhihong Li, Yosup Rew et al. · Journal of Medicinal Chemistry · 2014 · 290 citations · Full text

An Improved Preparation of Arylboronates:  Application in One-Pot Suzuki Biaryl Synthesis<sup>†</sup>

Lei Zhu, Jason Duquette, Mingbao Zhang · The Journal of Organic Chemistry · 2003 · 126 citations

An Improved Preparation of Arylboronates: Application in One‐Pot Suzuki Biaryl Synthesis.

Lei Zhu, Jason Duquette, Mingbao Zhang · ChemInform · 2003 · 105 citations · Full text

, , +8

Discovery and in Vivo Evaluation of (<i>S</i>)-<i>N</i>-(1-(7-Fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9<i>H</i>-purin-6-amine (AMG319) and Related PI3Kδ Inhibitors for Inflammation and Autoimmune Disease

Timothy D. Cushing, Xiaolin Hao, Youngsook Shin et al. · Journal of Medicinal Chemistry · 2014 · 84 citations

, , +23

Selective and Potent Morpholinone Inhibitors of the MDM2–p53 Protein–Protein Interaction

Ana Z. González, John Eksterowicz, Michael D. Bartberger et al. · Journal of Medicinal Chemistry · 2014 · 83 citations · Full text

Rows per page

1–5 of 16